Elsevier

Neurobiology of Aging

Volume 32, Issue 11, November 2011, Pages 2106.e7-2106.e11
Neurobiology of Aging

Genetic reports abstract
CR1 genotype is associated with entorhinal cortex volume in young healthy adults

https://doi.org/10.1016/j.neurobiolaging.2011.05.017Get rights and content

Abstract

Gene-brain structure associations of 3 recently discovered risk genes for Alzheimer's disease, CLU (rs11136000C>T), CR1 (rs6656401G>A), and PICALM (rs3851179G>A), were investigated in 2 independent cohorts of young healthy adults (n = 430 and n = 492, respectively). We assessed structural differences in 2 core structures of Alzheimer pathology, entorhinal cortex and hippocampus, by voxel-based morphometry using high-resolution magnetic resonance imaging (MRI) data. For CLU and PICALM no significant genotype-related differences in local gray matter volume were found. CR1 risk allele (A) carriers showed smaller local gray matter volume in the entorhinal cortex, as confirmed in both cohorts. This association, apparent in young healthy adults, might mediate susceptibility for Alzheimer's disease later in life.

Introduction

Late-onset Alzheimer's disease (AD) is a genetically complex disorder (Bertram et al., 2007). APOE contributes strongly to the heritability of AD (Corder et al., 1993), but the search for other genes has been difficult because of the small individual effect sizes of presumed risk genes. Recently, 2 large genome-wide association studies (GWAS) succeeded in identifying 3 new genes associated with AD: CLU, CR1, and PICALM (Harold et al., 2009, Lambert et al., 2009). However, the mechanisms behind the increase in AD susceptibility caused by these risk genes remain to be explored.

AD is associated with structural changes in the brain starting with anterior medial temporal lobe atrophy centered in entorhinal cortex and hippocampus (Braak and Braak, 1991, Hyman et al., 1984). For APOE, associations have been found between risk genotype and entorhinal and hippocampal volume in AD patients (Geroldi et al., 1999) as well as in healthy individuals (Shaw et al., 2007, Wishart et al., 2006). To investigate whether these AD-related brain regions also mediate the effects of the CLU, CR1, and PICALM risk alleles, we studied brain structure in 2 cohorts of young healthy adults. Structural differences in anterior medial temporal lobe regions, observed as early as in young adulthood, may contribute to the increased susceptibility for AD later in life.

Section snippets

Methods

Detailed description of the methods can be found in the Supplementary methods section. This study is part of the Brain Imaging Genetics (BIG) project running at the Radboud University Nijmegen (Medical Centre). Saliva and structural magnetic resonance imaging (MRI) data were collected from 922 healthy, highly educated (bachelor student level or higher) adults of Caucasian origin between 18 and 36 years of age, with no self-reported neurological or psychiatric history (for demographics see Table

Results

The participant demographics and genotype distributions are shown in Table 1. All genotypes were in Hardy-Weinberg Equilibrium (p > 0.05). Genotyping was successful in 100%, 97.9%, 98.3%, and 98.7% of the samples for CLU, CR1, PICALM, and APOE respectively.

VBM analysis of local gray matter volume in the entorhinal cortex and the hippocampus showed significant differences between genotypes. In the discovery cohort associations between CR1 genotype and local gray matter volume were found in the

Discussion

In this study we investigated associations of 3 recently identified AD risk genes, CLU, CR1, and PICALM with AD-related brain regions in young healthy adults. Whereas for CLU and PICALM no significant associations with local brain volume were found, carriers of the AD risk allele in CR1 showed smaller local gray matter volume in the entorhinal cortex. This finding was confirmed in a second, independent cohort. Dose effect analysis showed significant results, suggesting a possible additive

Disclosure statement

The authors report no conflicts of interest.

All participants gave written informed consent and the study was approved by the local ethics committee.

Acknowledgements

The authors thank all participants who took part in the study. The authors thank R. Makkinje and S. Kooijman for their support in genotyping and recruitment of participants. This project was partly funded by a grant from the Hersenstichting Nederland.

References (23)

  • G. Chételat et al.

    Relationship between atrophy and beta-amyloid deposition in Alzheimer disease

    Ann. Neurol

    (2010)
  • Cited by (0)

    View full text